Baebies Reaches Milestone of 10 Million Newborn Screening Tests Delivered
DURHAM, NC / ACCESSWIRE / March 18, 2021 / Baebies, a growth-stage company developing innovative products to provide a healthy start...
Year: 2021
Chiesi Group announces performance growth in 2020
Chiesi Group currently employs 6,389 people worldwide, 2,119 of whom are in Italy, and has a turnover of €2.229 billion.Chiesi’s...
Sorrento Announces First Patient Treated in Phase IB AL Amyloidosis Trial with STI-6129, an Anti-CD38 Antibody-Drug Conjugate
STI-6129 is an antibody-drug conjugate (ADC) composed of a fully human monoclonal anti-CD38 antibody covalently bound by a proprietary chemical...
Ossium Health Raises $63M Series B to Revolutionize Bioengineering
SAN FRANCISCO, March 18, 2021 (GLOBE NEWSWIRE) -- Ossium Health, a therapeutics company harnessing the power of stem cell science...
Allied Files Provisional Patent for Psilocybin Therapeutic Invention Seeking Drug Indication for Mental Health Depression and Anxiety Applications
KELOWNA, British Columbia, March 18, 2021 (GLOBE NEWSWIRE) -- Allied Corp. ("Allied") (OTCQB: ALID), an international medical cannabis company focused on...
Qualigen Therapeutics, Inc. to present at the Benzinga Biotech Small Cap Conference
CARLSBAD, Calif., March 18, 2021 (GLOBE NEWSWIRE) -- Qualigen Therapeutics, Inc. (NASDAQ: QLGN), a biotechnology company focused on developing novel...
Skye Bioscience to Present at Benzinga Biotech Small Cap Conference
San Diego, Calif., March 18, 2021 (GLOBE NEWSWIRE) -- Skye Bioscience, Inc. (OTCQB: SKYE) (“SKYE” or the “Company”), a biopharmaceutical...
Yield10 Bioscience to Present at the Benzinga Biotech Small Cap Conference on March 25, 2021
WOBURN, Mass., March 18, 2021 (GLOBE NEWSWIRE) -- Yield10 Bioscience, Inc. (Nasdaq: YTEN), an agricultural bioscience company, today announced that...
ICU Medical, Inc. to Participate in Fireside Chat at the KeyBanc Life Sciences & MedTech Investor Forum
SAN CLEMENTE, Calif., March 18, 2021 (GLOBE NEWSWIRE) -- ICU Medical, Inc. (Nasdaq:ICUI), a leader in the development, manufacture and...
DAXOR CORPORATION TO PARTICIPATE IN BENZINGA BIOTECH SMALL CAP CONFERENCE
NEW YORK, March 18, 2021 (GLOBE NEWSWIRE) -- Daxor Corporation (NYSE: DXR), the global leader in blood volume measurement technology,...
American Cannabis Company, Inc. Announces Formation of Advisory Board
DENVER, CO, March 18, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- American Cannabis Company, Inc. (OTCQB: AMMJ) (“ACC” or “Company”)...
Assure Holdings Appoints Leading Orthopaedic and Spinal Surgeon Isador Lieberman to Medical Advisory Committee
DENVER, March 18, 2021 (GLOBE NEWSWIRE) -- Assure Holdings Corp. (the “Company” or “Assure”) (TSXV: IOM; OTCQB: ARHH), a provider...
Avricore Health Finalizes Agreement With Avrok Laboratories to Offer Real-Time Covid-19 Screening
The companies agree to offer HealthTab™ and COVID-19 rapid-antigen tests at resort locations, delivering fast and accurate results for travellers...
Dyadic Advancing Towards Human Clinical Trial of its SARS-CoV-2-S-RBD vaccine candidate, DYAI-100
Israel Institute for Biological Research (IIBR) reports successful challenge studies using human ACE2 transgenic mice vaccinated with SARS-CoV-2-S-RBD vaccine candidate...
MEDIROM Healthcare Technologies Inc., Announces its latest Key Performance Indicators (KPIs)
NEW YORK, March 18, 2021 (GLOBE NEWSWIRE) -- MEDIROM Healthcare Technologies Inc. (Nasdaq CM:MRM), a Japanese based holistic healthcare Company...
Cancer Genetics Announces Roland J. Carrillo, PhD as Vice President of Business Development
RUTHERFORD, N.J., March 18, 2021 (GLOBE NEWSWIRE) -- Cancer Genetics, Inc. (the “Company”) (Nasdaq: CGIX), an emerging leader in novel...
APIE Therapeutics Prepares to Advance Pipeline Programs with Appointment of Robert Willette, Ph.D. as Chief Scientific Officer
Cary, NC, March 18, 2021 (GLOBE NEWSWIRE) -- APIE Therapeutics, a preclinical biopharma company pioneering microvasculature endothelium drug development by...
Helsinn publishes PROVe MF-CTCL study providing new data for mechlorethamine gel use in a real-world setting
Helsinn publishes PROVe MF-CTCL study providing new data for mechlorethamine gel use in a real-world setting Lugano, Switzerland, March 18,...
Eyenovia to Report Fourth Quarter and Full Year 2020 Results on Thursday, March 25
Company to host an investor conference call and webcast at 4:30pm ET on that dayNEW YORK, March 18, 2021 (GLOBE...
Celularity Announces Fast Track Designation by the FDA for its Natural Killer Cell Therapy CYNK-001 in the Treatment of Recurrent Glioblastoma Multiforme
FLORHAM PARK, N.J., March 18, 2021 (GLOBE NEWSWIRE) -- Celularity Inc. (“Celularity”), a clinical-stage biotechnology company, leading the next evolution...